1. Home
  2. Health
  3. Heart Disease

Sudden Death After Heart Attacks

MADIT II and the appropriate use of the implantable defibrillator

By Richard N. Fogoros, M.D., About.com

Created: November 30, 2003

About.com Health's Disease and Condition content is reviewed by our Medical Review Board

Unfortunately, there has been no formal "indication" for using implantable defibrillators in heart attack survivors. These devices have been reserved for patients who have already had cardiac arrests from ventricular fibrillation, and who were fortunate enough to be resuscitated - a relatively very small population of individuals. The reticence to use implantable defibrillators in larger groups of patients was originally based on the "newness" of the therapy - did it really work as well as it was supposed to? - and on the fact that for the first decade or so of its use, the surgery necessary for implanting this device was a major undertaking. Today, when the necessary surgery is nearly as simple as implanting a standard pacemaker, and when the device has proven its effectiveness to an astounding degree, the reticence to apply it to larger groups is based on cost. "Before applying this expensive treatment to large groups of people," the experts said, "we need well-designed clinical studies to show it works in those larger groups."

This week in the New England Journal of Medicine, such a study was reported. The MADIT II trial enrolled more than a thousand patients who had prior heart attacks and whose left ventricular ejection fractions (a measure of the pumping efficiency of the heart) was less than 30% were randomized to receive either standard medical therapy, or the same standard medical therapy plus the implantable defibrillator. The results were striking: patients who received the defibrillator experienced a 30% reduction in mortality compared to patients without the defibrillator. As a result of MADIT II, the FDA is being petitioned to allow use of the implantable defibrillator in heart attack survivors with reduced ejection fractions. The FDA is expected to grant this new indication relatively soon.

But based on the reaction of doctors and insurers to this new data, a sudden surge in defibrillator implantations may not occur.

Why preventing sudden death is low on everyone's priority list

Three reasons:
  • 1) Insurance companies and the feds (i.e. Medicare) like sudden death. It is not only the cheapest way to die, but also its victims (most of whom have some form of underlying heart disease) immediately stop consuming precious health care dollars.
  • 2) Doctors don't like to think about sudden death because doing something to prevent it is expensive. The implantable defibrillator costs roughly $20,000, and every time a doctor uses one, he/she makes either an insurance company or the feds (the ones who pay the bills) unhappy.
  • 3) Unlike AIDS, breast cancer, or the heartbreak of psoriasis, sudden death has no constituency among patient groups. By the time a person realizes it's a problem, he/she may have enough time to utter a gasp, like poor John, but certainly not enough time to found a political action committee. Patients simply aren't demanding that reluctant doctors implant these devices, or that insurance companies pay for them.
So for nearly everyone in the health care system, the course of least resistance - and the safest course of action - is simply to ignore the problem. Frankly, unless heart attack survivors specifically ask about the possibility of sudden death - which is a reasonably likely occurrence in many patients who have survived a heart attack - the topic is unlikely to come up.

What this new information means to you

  • 1) If you have had a heart attack, know your ejection fraction. The ejection fraction is routinely measured after a heart attack, either during a heart catheterization, a MUGA scan, or a thallium study. If it is 30% or lower, you are at a relatively high risk for sudden death, and it is now known that an implantable defibrillator will substantially increase your odds of long-term survival. (If the ejection fraction was never measured, go get yourself another doctor.)
  • 2) If you do fall into this "high-risk" category, make sure you talk to your doctor about preventing sudden death. If the doctor demurs, assuring you that your beta blockers, ACE inhibitors statins, and aspirin treatment is enough to prevent sudden death, you demur right back. In MADIT II, patients not receiving the implantable defibrillator were getting all those drugs - and still had a 30% higher mortality than patients who received the defibrillator.
  • 3) If you think you fit into this high-risk category but feel so well that you just can't believe that sudden death is a possibility, re-read the scenario that began this article. Then stop to think of all the people you know in your life who died suddenly from a "massive heart attack." (Most people over 30 have lived long enough to lose several acquaintances in this way.) And think of what their sudden departure did to their families. That could very easily be you and your family, unless you shame your doctor into taking now-proven and appropriate action.

Explore Heart Disease

More from About.com

About.com is accredited by the Health On the Net Foundation, which promotes reliable and trusted online health information.
  1. Home
  2. Health
  3. Heart Disease
  4. Coronary Artery Disease
  5. Heart Attack
  6. Sudden death after heart attack

©2008 About.com, a part of The New York Times Company.

All rights reserved.